Enric Caubet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Enric Caubet has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Ramon Vilallonga
Endocrine-Metabolic and Bariatric Surgery Unit, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain
14 shared publications José Manuel Fort
Unidad de Cirugía Endocrina, Servicio de Cirugía General, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España
11 shared publications- Oscar Gonzalez
Endocrine, Metabolic and Bariatric Unit, General Surgery Department, Vall d'Hebron University Hospital, Center of Excellence for the EAC-BC, Passeig de la Vall d'Hebron 119-129, 08035 Barcelona, Spain
11 shared publications - Manel Armengol
Abdominal Wall Surgery Unit, Department of General Surgery, Hospital Universitari Vall d'Hebrón, Universitat Autònoma de Barcelona, Barcelona, Spain
10 shared publications - Jose Maria Balibrea
Servicio de Cirugía General y Digestiva, Hospital Germans Trias i Pujol, Universitat Autónoma de Barcelona, Badalona, Barcelona, España
7 shared publications - Albert Lecube
Endocrinology and Nutrition Department, Vall d’Hebron University, Hospital Vall d′Hebron Research Institute (ISS IR-HUVH-VHIR), Barcelona, Spain
6 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Endocrinología, Diabetes y Nutrición
- Vol. 64 (8) , 451-455
Biopsia selectiva del ganglio centinela en el carcinoma papilar de tiroides en pacientes sin evidencia preoperatoria de metástasis ganglionar
- 1 October 2017
- Published by Elsevier in Endocrinología, Diabetes y Nutrición
- Vol. 64 (8) , 451-455
Biopsia selectiva del ganglio centinela en el carcinoma papilar de tiroides en pacientes sin evidencia preoperatoria de metástasis ganglionar
- 1 October 2017
- Published by Elsevier in Endocrinología, Diabetes y Nutrición (English Ed.)
- Vol. 64 (8) , 451-455
Selective sentinel lymph node biopsy in papillary thyroid carcinoma in patients with no preoperative evidence of lymph node metastasis
- 1 October 2017
- Published by Elsevier in Endocrinología, Diabetes y Nutrición (English Ed.)
- Vol. 64 (8) , 451-455
Selective sentinel lymph node biopsy in papillary thyroid carcinoma in patients with no preoperative evidence of lymph node metastasis
- 2 December 2016
- Published by Springer Nature in Obesity Surgery
- Vol. 27 (5) , 1302-1308
Mid-Term Results and Responsiveness Predictors After Two-Step Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy
In patients with insufficient weight loss after sleeve gastrectomy (SG) or in super obese individuals, among many surgical options available, a single-anastomosis duodeno-ileal bypass (SADI) after SG (SADI-S) could be considered. Due to the limited information available about the use of SADI as a second-step procedure, the objective of this study was to evaluate the mid-term results and responsiveness of SADI after sleeve gastrectomy. We present prospective data from 30 consecutive patients with a mean BMI of 40.1 kg/m2, a mean excess weight of 44.7 kg, and a mean excess weight loss (EWL) of 37.5%, who were submitted to a SADI as a second-step revisional procedure. There were no intraoperative complications. Four early complications (13.34%) occurred within the first 24 postoperative hours. Six, 12, and 24-month follow-up number of patients available was 30 (100%), 22 (73.3%), and 16 (53.34%), respectively. Percent total weight loss (%WL) was 28.1 at the time of revision and 46.26% 24 months after SADI. Global %EWL was 78.93 ± 35.5. The complete remission rate after SG was 50% for diabetes, 33.3% for dyslipidemia, and 25% for hypertension, and 71.4%, 31.2%, and 27.7%, respectively, after SADI. Three (10%) patients required revisional surgery due to hypoalbuminemia. SADI as a second-step strategy in super obese patients or after failed SG offers a more than satisfactory ponderal weight loss and an acceptable comorbidities resolution. However, the risk of severe malnutrition after distal SADI-S makes necessary a careful patient selection.
- 2 December 2016
- Published by Springer Nature in Obesity Surgery
- Vol. 27 (5) , 1302-1308
Mid-Term Results and Responsiveness Predictors After Two-Step Single-Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy
In patients with insufficient weight loss after sleeve gastrectomy (SG) or in super obese individuals, among many surgical options available, a single-anastomosis duodeno-ileal bypass (SADI) after SG (SADI-S) could be considered. Due to the limited information available about the use of SADI as a second-step procedure, the objective of this study was to evaluate the mid-term results and responsiveness of SADI after sleeve gastrectomy. We present prospective data from 30 consecutive patients with a mean BMI of 40.1 kg/m2, a mean excess weight of 44.7 kg, and a mean excess weight loss (EWL) of 37.5%, who were submitted to a SADI as a second-step revisional procedure. There were no intraoperative complications. Four early complications (13.34%) occurred within the first 24 postoperative hours. Six, 12, and 24-month follow-up number of patients available was 30 (100%), 22 (73.3%), and 16 (53.34%), respectively. Percent total weight loss (%WL) was 28.1 at the time of revision and 46.26% 24 months after SADI. Global %EWL was 78.93 ± 35.5. The complete remission rate after SG was 50% for diabetes, 33.3% for dyslipidemia, and 25% for hypertension, and 71.4%, 31.2%, and 27.7%, respectively, after SADI. Three (10%) patients required revisional surgery due to hypoalbuminemia. SADI as a second-step strategy in super obese patients or after failed SG offers a more than satisfactory ponderal weight loss and an acceptable comorbidities resolution. However, the risk of severe malnutrition after distal SADI-S makes necessary a careful patient selection.
- Open Access
- 16 November 2016
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2016
Brown tumor of the jaw after pregnancy and lactation in a MEN1 patient
Summary: Skeletal manifestations of primary hyperparathyroidism (pHPT) include brown tumors (BT), which are osteoclastic focal lesions often localized in the jaws. Brown tumors are a rare manifestation of pHTP in Europe and USA; however, they are frequent in developing countries, probably related to vitamin D deficiency and longer duration and severity of disease. In the majority of cases, the removal of the parathyroid adenoma is enough for the bone to remineralize, but other cases require surgery. Hyperparathyroidism in MEN1 develops early, and is multiglandular and the timing of surgery remains questionable. To our knowledge, there are no reports of BT in MEN 1 patients. We present a 29-year-old woman with MEN 1 who developed a brown tumor of the jaw 24 months after getting pregnant, while breastfeeding. Serum corrected calcium remained under 2.7 during gestation, and at that point reached a maximum of 2.82 mmol/L. Concomitant PTH was 196 pg/mL, vitamin D 13.7 ng/mL and alkaline phosphatase 150 IU/L. Bone mineral density showed osteopenia on spine and femoral neck (both T -scores = −1.6). Total parathyroidectomy was performed within two weeks, with a failed glandular graft autotransplantation, leading to permanent hypoparathyroidism. Two months after removal of parathyroid glands, the jaw tumor did not shrink; thus, finally it was successfully excised. We hypothesize that higher vitamin D and mineral requirements during maternity may have triggered an accelerated bone resorption followed by appearance of the jaw BT. We suggest to treat pHPT before planning a pregnancy in MEN1 women or otherwise supplement with vitamin D, although this approach may precipitate severe hypercalcemia. Learning points: Brown tumors of the jaw can develop in MEN 1 patients with primary hyperparathyroidism at a young age (less than 30 years). Pregnancy and lactation might trigger brown tumors by increasing mineral and vitamin D requirements. Early parathyroidectomy is advisable in MEN 1 patients with primary hyperparathyroidism, at least before planning a pregnancy. Standard bone mineral density does not correlate with the risk of appearance of a brown tumor. Removal of parathyroid glands does not always lead to the shrinkage of the brown tumor, and surgical excision may be necessary.
- 16 November 2016
- Published by Bioscientifica in Endocrinology, Diabetes & Metabolism Case Reports
- Vol. 2016
Open AccessBrown tumor of the jaw after pregnancy and lactation in a MEN1 patient
Summary: Skeletal manifestations of primary hyperparathyroidism (pHPT) include brown tumors (BT), which are osteoclastic focal lesions often localized in the jaws. Brown tumors are a rare manifestation of pHTP in Europe and USA; however, they are frequent in developing countries, probably related to vitamin D deficiency and longer duration and severity of disease. In the majority of cases, the removal of the parathyroid adenoma is enough for the bone to remineralize, but other cases require surgery. Hyperparathyroidism in MEN1 develops early, and is multiglandular and the timing of surgery remains questionable. To our knowledge, there are no reports of BT in MEN 1 patients. We present a 29-year-old woman with MEN 1 who developed a brown tumor of the jaw 24 months after getting pregnant, while breastfeeding. Serum corrected calcium remained under 2.7 during gestation, and at that point reached a maximum of 2.82 mmol/L. Concomitant PTH was 196 pg/mL, vitamin D 13.7 ng/mL and alkaline phosphatase 150 IU/L. Bone mineral density showed osteopenia on spine and femoral neck (both T -scores = −1.6). Total parathyroidectomy was performed within two weeks, with a failed glandular graft autotransplantation, leading to permanent hypoparathyroidism. Two months after removal of parathyroid glands, the jaw tumor did not shrink; thus, finally it was successfully excised. We hypothesize that higher vitamin D and mineral requirements during maternity may have triggered an accelerated bone resorption followed by appearance of the jaw BT. We suggest to treat pHPT before planning a pregnancy in MEN1 women or otherwise supplement with vitamin D, although this approach may precipitate severe hypercalcemia. Learning points: Brown tumors of the jaw can develop in MEN 1 patients with primary hyperparathyroidism at a young age (less than 30 years). Pregnancy and lactation might trigger brown tumors by increasing mineral and vitamin D requirements. Early parathyroidectomy is advisable in MEN 1 patients with primary hyperparathyroidism, at least before planning a pregnancy. Standard bone mineral density does not correlate with the risk of appearance of a brown tumor. Removal of parathyroid glands does not always lead to the shrinkage of the brown tumor, and surgical excision may be necessary.
- Open Access
- 1 June 2016
- Published by Elsevier in BBA Clinical
- Vol. 5, 54-65
Diabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese
- 1 June 2016
- Published by Elsevier in BBA Clinical
- Vol. 5, 54-65
Open AccessDiabetic and dyslipidaemic morbidly obese exhibit more liver alterations compared with healthy morbidly obese
- 13 May 2016
- Published by Bioscientifica in Endocrine Abstracts
Left adrenal Ectopic cushing syndrome even more challenging
Background: The Ectopic ACTH Syndromes (EAS) often associated with severe hypercortisolism are really a challenge. Case presentation: We report the case of a 48-year-old woman, newly diagnosed with hypertension, hypokalemia despite renin-angiotensin blockers intake, and complaints of intense fatigue, muscular weakness, and easy bruising, which worse in four months. EAS was biochemically confirmed, but two urinary catecholamines collection were negatives despite a left adrenal topography in all image studies included MIBG was found. The patient dramatically worse after lanreotide treatment, we hypothesize, the lack of response to somatostatin analogues could be explained because of the extremely high hypercortisolism that downregulate somatostatin receptor type 2 expression, so after ketoconazole therapy and cortisol normalization, we repeat SSRS scan, but we do not find any change. Finally adrenal left gland and an associated extra adrenal ganglioneuroma were removed. Surprisingly only the adrenal gland had significant staining of ACTH. After removal, blood pressure was normalized without pills, hypercortisolemic parameters and the clinical symptoms were resolved. Conclusion: We highlight surgery, if is feasible, in EAS, is ever the best choice and can be curative. Regarding pharmacological options we emphasized glucocorticoids can decrease the somatostatin receptor type 2, expression in tumor, with diagnostic and treatment implications. Finally we propose 68Gallium-SSTR-PET/CT, and pasireotide with somatostatin receptor type 5 affinity, could be better diagnostic and treatment alternatives in patients with very high cortisol levels.
- 13 May 2016
- Published by Bioscientifica in Endocrine Abstracts
Left adrenal Ectopic cushing syndrome even more challenging
Background: The Ectopic ACTH Syndromes (EAS) often associated with severe hypercortisolism are really a challenge. Case presentation: We report the case of a 48-year-old woman, newly diagnosed with hypertension, hypokalemia despite renin-angiotensin blockers intake, and complaints of intense fatigue, muscular weakness, and easy bruising, which worse in four months. EAS was biochemically confirmed, but two urinary catecholamines collection were negatives despite a left adrenal topography in all image studies included MIBG was found. The patient dramatically worse after lanreotide treatment, we hypothesize, the lack of response to somatostatin analogues could be explained because of the extremely high hypercortisolism that downregulate somatostatin receptor type 2 expression, so after ketoconazole therapy and cortisol normalization, we repeat SSRS scan, but we do not find any change. Finally adrenal left gland and an associated extra adrenal ganglioneuroma were removed. Surprisingly only the adrenal gland had significant staining of ACTH. After removal, blood pressure was normalized without pills, hypercortisolemic parameters and the clinical symptoms were resolved. Conclusion: We highlight surgery, if is feasible, in EAS, is ever the best choice and can be curative. Regarding pharmacological options we emphasized glucocorticoids can decrease the somatostatin receptor type 2, expression in tumor, with diagnostic and treatment implications. Finally we propose 68Gallium-SSTR-PET/CT, and pasireotide with somatostatin receptor type 5 affinity, could be better diagnostic and treatment alternatives in patients with very high cortisol levels.
- 13 May 2016
- Published by Bioscientifica in Endocrine Abstracts
Macro, but not micrometastases, detected by OSNA technique are related with more aggressive papillary thyroid cancer features
Introduction: Classically, risk stratification in papillary thyroid carcinoma (PTC) assigned the same magnitude of risk to all patients with regional lymph node involvement (N1 disease). However, specific lymph node characteristics (such as size, number, extension, etc.) will allow individualizing treatment and follow-up. One-Step Nucleic Acid Amplification (OSNA) measures the number of copies of mRNA of cytokeratin 19 (CK19) as a marker of lymph node metastasis. Thus, copy numbers between 250 and 5000 were considered micrometastases (mM1), and more than 5000 copies were designated as macrometastases (MM1). Objective: To analyze the influence of OSNA lymph node metastasis classification in the histological characteristics of PTC in patients submitted to lymph node dissection (LND). Material and methods: LND from 40 patients (28 female, mean age 49±15 years old) were evaluated. Lymph node metastases were detected using OSNA. Metastases characteristics include total tumoral load (TTL), TTL per total lymph node weight (TTL/TLNW), and mM1 versus MM1. According to the metastases status tumor related variables were studied. Results: A total of 513 lymph nodes were found, with a mean (S.D.) of 12.8 (9.5) per patient. Thirty LND were considered positive for metastases (75%). There were no significant differences in tumor histological variables and TTL or TTL/TLMW. According to mM1 versus MM1 status, there were 10 (25%) patients with no lymph node involvement, 11 (27.5%) with only mM1, and 19 (47.5%) with at least one MM1. Only this last group was significantly related with primary tumor size (P=0.04), vascular invasion (P=0.03), extrathyroidal extension (P=0.04) and positive margin (P=0.04). Conclusion: Lymph node macrometastases detected by OSNA are related with more aggressive PTC. OSNA could be a useful technique to improve lymph node metastases characterization.
- 13 May 2016
- Published by Bioscientifica in Endocrine Abstracts
Macro, but not micrometastases, detected by OSNA technique are related with more aggressive papillary thyroid cancer features
Introduction: Classically, risk stratification in papillary thyroid carcinoma (PTC) assigned the same magnitude of risk to all patients with regional lymph node involvement (N1 disease). However, specific lymph node characteristics (such as size, number, extension, etc.) will allow individualizing treatment and follow-up. One-Step Nucleic Acid Amplification (OSNA) measures the number of copies of mRNA of cytokeratin 19 (CK19) as a marker of lymph node metastasis. Thus, copy numbers between 250 and 5000 were considered micrometastases (mM1), and more than 5000 copies were designated as macrometastases (MM1). Objective: To analyze the influence of OSNA lymph node metastasis classification in the histological characteristics of PTC in patients submitted to lymph node dissection (LND). Material and methods: LND from 40 patients (28 female, mean age 49±15 years old) were evaluated. Lymph node metastases were detected using OSNA. Metastases characteristics include total tumoral load (TTL), TTL per total lymph node weight (TTL/TLNW), and mM1 versus MM1. According to the metastases status tumor related variables were studied. Results: A total of 513 lymph nodes were found, with a mean (S.D.) of 12.8 (9.5) per patient. Thirty LND were considered positive for metastases (75%). There were no significant differences in tumor histological variables and TTL or TTL/TLMW. According to mM1 versus MM1 status, there were 10 (25%) patients with no lymph node involvement, 11 (27.5%) with only mM1, and 19 (47.5%) with at least one MM1. Only this last group was significantly related with primary tumor size (P=0.04), vascular invasion (P=0.03), extrathyroidal extension (P=0.04) and positive margin (P=0.04). Conclusion: Lymph node macrometastases detected by OSNA are related with more aggressive PTC. OSNA could be a useful technique to improve lymph node metastases characterization.
- Open Access
- 30 September 2015
- Published by Hindawi Limited in Journal of Obesity
- Vol. 2015, 1-6
Robotically Assisted Single Anastomosis Duodenoileal Bypass after Previous Sleeve Gastrectomy Implementing High Valuable Technology for Complex Procedures
Staged bariatric procedures in high risk patients are a common used strategy for morbid obese patients nowadays. After previous sleeve gastrectomy, surgical treatments in order to complete weight loss or comorbidities improvements or resolutions are possible. One strategy is to perform a novel technique named SADI (single anastomosis duodenoileal bypass-sleeve). We present the technique for totally intracorporeal robotically assisted SADI using five ports and a liver retractor. We aim to see if the robotic technology offers more advantageous anastomosis and dissection obtained by the robotic approach in comparison to standard laparoscopy. The safety, feasibility, and reproducibility of a minimally invasive robotic surgical approach to complex abdominal operations such as SADI are discussed. Staged bariatric procedures in high risk patients are a common used strategy for morbid obese patients nowadays. After previous sleeve gastrectomy, surgical treatments in order to complete weight loss or comorbidities improvements or resolutions are possible. One strategy is to perform a novel technique named SADI (single anastomosis duodenoileal bypass-sleeve). We present the technique for totally intracorporeal robotically assisted SADI using five ports and a liver retractor. We aim to see if the robotic technology offers more advantageous anastomosis and dissection obtained by the robotic approach in comparison to standard laparoscopy. The safety, feasibility, and reproducibility of a minimally invasive robotic surgical approach to complex abdominal operations such as SADI are discussed.
- 30 September 2015
- Published by Hindawi Limited in Journal of Obesity
- Vol. 2015, 1-6
Open AccessRobotically Assisted Single Anastomosis Duodenoileal Bypass after Previous Sleeve Gastrectomy Implementing High Valuable Technology for Complex Procedures
Staged bariatric procedures in high risk patients are a common used strategy for morbid obese patients nowadays. After previous sleeve gastrectomy, surgical treatments in order to complete weight loss or comorbidities improvements or resolutions are possible. One strategy is to perform a novel technique named SADI (single anastomosis duodenoileal bypass-sleeve). We present the technique for totally intracorporeal robotically assisted SADI using five ports and a liver retractor. We aim to see if the robotic technology offers more advantageous anastomosis and dissection obtained by the robotic approach in comparison to standard laparoscopy. The safety, feasibility, and reproducibility of a minimally invasive robotic surgical approach to complex abdominal operations such as SADI are discussed. Staged bariatric procedures in high risk patients are a common used strategy for morbid obese patients nowadays. After previous sleeve gastrectomy, surgical treatments in order to complete weight loss or comorbidities improvements or resolutions are possible. One strategy is to perform a novel technique named SADI (single anastomosis duodenoileal bypass-sleeve). We present the technique for totally intracorporeal robotically assisted SADI using five ports and a liver retractor. We aim to see if the robotic technology offers more advantageous anastomosis and dissection obtained by the robotic approach in comparison to standard laparoscopy. The safety, feasibility, and reproducibility of a minimally invasive robotic surgical approach to complex abdominal operations such as SADI are discussed.
- 1 April 2015
- Published by Elsevier in Clinical Nutrition
- Vol. 34 (2) , 276-283
Haematological parameters and serum trace elements in “healthy” and “unhealthy” morbidly obese patients before and after gastric bypass
- 1 April 2015
- Published by Elsevier in Clinical Nutrition
- Vol. 34 (2) , 276-283
Haematological parameters and serum trace elements in “healthy” and “unhealthy” morbidly obese patients before and after gastric bypass
- 23 December 2014
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 28 (3) , 153-159
Detection of Thyroid Papillary Carcinoma Lymph Node Metastases UsingOne Step Nucleic Acid Amplification(OSNA): Preliminary Results
Purpouse: One Step Nucleic Acid Amplification (OSNA) has been previously proposed for the diagnosis of lymph node metastases (LNMs) from several malignant conditions by quantifying the number of copies of cytokeratin 19 mRNA. Our aim was to evaluate the results obtained by OSNA in the lymph nodes of patients with papillary thyroid carcinoma (PTC) by comparing our results with the findings observed using standard pathological examination. Fifty human lymph nodes (from five patients with diagnosed PTC) were studied. Each node was divided into two: one half was used for molecular study ("OSNA-node"), and the other half was used for conventional staining with hematoxylin and eosin ("HE-non-OSNA node"). Three cytological imprints using Papanicolaou and May-Grunwald-Giemsa strains were obtained from both node halves. The results from each technique were compared, and ROC analysis was performed. The OSNA study showed 22 positive samples for LNM (44%), which demonstrate a high concordance rate with the results observed using conventional pathological examination (cytology of "OSNA-node" and HE of "Non-OSNA node") with specificity and sensitivity values greater than 86% and 89%, respectively. However, both comparisons differed in the number of copies of mRNA as the best cut-off (260 copies in the first case and 93 in the second case). The OSNA results for the detection of LNM in patients with PTC are comparable with those observed using conventional techniques. However, its quantitative nature could be useful to more accurately detect lymph node involvement.
- 23 December 2014
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 28 (3) , 153-159
Detection of Thyroid Papillary Carcinoma Lymph Node Metastases UsingOne Step Nucleic Acid Amplification(OSNA): Preliminary Results
Purpouse: One Step Nucleic Acid Amplification (OSNA) has been previously proposed for the diagnosis of lymph node metastases (LNMs) from several malignant conditions by quantifying the number of copies of cytokeratin 19 mRNA. Our aim was to evaluate the results obtained by OSNA in the lymph nodes of patients with papillary thyroid carcinoma (PTC) by comparing our results with the findings observed using standard pathological examination. Fifty human lymph nodes (from five patients with diagnosed PTC) were studied. Each node was divided into two: one half was used for molecular study ("OSNA-node"), and the other half was used for conventional staining with hematoxylin and eosin ("HE-non-OSNA node"). Three cytological imprints using Papanicolaou and May-Grunwald-Giemsa strains were obtained from both node halves. The results from each technique were compared, and ROC analysis was performed. The OSNA study showed 22 positive samples for LNM (44%), which demonstrate a high concordance rate with the results observed using conventional pathological examination (cytology of "OSNA-node" and HE of "Non-OSNA node") with specificity and sensitivity values greater than 86% and 89%, respectively. However, both comparisons differed in the number of copies of mRNA as the best cut-off (260 copies in the first case and 93 in the second case). The OSNA results for the detection of LNM in patients with PTC are comparable with those observed using conventional techniques. However, its quantitative nature could be useful to more accurately detect lymph node involvement.